Fatal pulmonary fibrosis from low-dose bleomycin therapy.
South Med J
; 80(5): 646-9, 1987 May.
Article
em En
| MEDLINE
| ID: mdl-2437659
ABSTRACT
Six weeks after receiving a total dose of 20 units of bleomycin sulfate as part of BACOP therapy for non-Hodgkin's lymphoma, our patient had dyspnea and cough with marked hypoxemia. Open lung biopsy established the diagnosis of "bleomycin lung," confirmed by postmortem examination. Fatal bleomycin pulmonary toxicity can develop with any dosage, and routine tests are incapable of detecting early, reversible toxicity.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fibrose Pulmonar
/
Bleomicina
Limite:
Aged
/
Humans
/
Male
Idioma:
En
Revista:
South Med J
Ano de publicação:
1987
Tipo de documento:
Article